Skip To Main Content
Robert Brackner on Muck Rack

Robert Brackner

Raleigh
As seen in: MedCity News, BioProcess International Magazine, Xtalks
PR rep, F&B guru, travel aficionado, outdoorsman and Wolfpack alumnus - These opinions are mine

Get in touch with Robert

Contact Robert, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Robert Brackner’s Biography

Read Full Bio →

Public Relations Specialist who has spent a career building businesses in different industries. From the closed boardrooms of executive management to the frontlines of sales there is seldom a situation I have not helped precipitate or diffuse.

Articles

Fast-Tracking Hope: Optimizing Precision Logistics for Advanced Therapies to Treat Rare Disease Patients

|
By Rohin Iyer, Robert Brackner, Terra Wolfe Lewis
| Xtalks Verified
The US Food and Drug Administration (FDA) defines a rare disease as a disease with fewer than 200,000 patients in the US. Paradoxically, despite this apparently low number of occurrences, over 7,000 rare diseases affect a staggering 30 million patients in the US alone, thereby necessitating solutions to advance their development and ensure a flawless journey from vein-to-vein.
Open in Who Shared Issue with article?

Empowering Healthcare for the Delivery of Advanced Therapies

|
By Rohin Iyer, Robert Brackner
| BioProcess International Magazine Verified
The advent of advanced therapy medicinal products (ATMPs) has ushered in a new age of healthcare by providing curative solutions to some of the world’s most debilitating diseases. ATMPs represent an inflection point in our industry’s ability to improve patient treatment.
Open in Who Shared Issue with article?

Vitality in the Supply Chain: The Limitless Potential of ATMPs Original

|
By Rohin Iyer, Robert Brackner
| MedCity News Verified
In laboratories around the globe, scientists are diligently researching the limitless potential of advanced therapeutic medicinal products (ATMPs). These groundbreaking therapies are changing the face of healthcare by harnessing the potential of the human body for healing. Using cells, proteins, antibodies, tissues and nucleic acids as “living” therapies is simultaneously promising, but also brings unique challenges from a manufacturing, supply chain, and patient treatment standpoint.
Open in Who Shared View Duplicates (2) Issue with article?
See all 3 articles